173 related articles for article (PubMed ID: 19856596)
1. Vesicant extravasation from an implanted venous access port.
Wickham R
Oncology (Williston Park); 2009 Apr; 23(4 Suppl Nurse Ed):34-8. PubMed ID: 19856596
[TBL] [Abstract][Full Text] [Related]
2. Developing extravasation protocols and monitoring outcomes.
Camp-Sorrell D
J Intraven Nurs; 1998; 21(4):232-9. PubMed ID: 9866539
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy extravasation from implanted ports.
Schulmeister L; Camp-Sorrell D
Oncol Nurs Forum; 2000 Apr; 27(3):531-8; quiz 539-40. PubMed ID: 10785905
[TBL] [Abstract][Full Text] [Related]
4. Venous access ports: frequency and management of complications in oncology patients.
Jordan K; Behlendorf T; Surov A; Kegel T; Maher G; Wolf HH
Onkologie; 2008 Jul; 31(7):404-10. PubMed ID: 18596390
[TBL] [Abstract][Full Text] [Related]
5. Reducing the risks of infiltration and extravasation.
Rosenthal K
Nursing; 2007; 37 Suppl Med():4-8. PubMed ID: 18163033
[No Abstract] [Full Text] [Related]
6. Advances in venous access devices and nursing management strategies.
Wickham RS
Nurs Clin North Am; 1990 Jun; 25(2):345-64. PubMed ID: 2110664
[TBL] [Abstract][Full Text] [Related]
7. Additional issues raised on blood returns and ports.
Morris DJ
Oncol Nurs Forum; 2000 Sep; 27(8):1202-3. PubMed ID: 11013901
[No Abstract] [Full Text] [Related]
8. Extravasation management: clinical update.
Schulmeister L
Semin Oncol Nurs; 2011 Feb; 27(1):82-90. PubMed ID: 21255716
[TBL] [Abstract][Full Text] [Related]
9. Vesicant extravasation: myths and realities.
Boyle DM; Engelking C
Oncol Nurs Forum; 1995; 22(1):57-67. PubMed ID: 7708525
[TBL] [Abstract][Full Text] [Related]
10. Antineoplastic vesicant extravasation.
Beason R
J Intraven Nurs; 1990; 13(2):111-4. PubMed ID: 2313459
[TBL] [Abstract][Full Text] [Related]
11. Reader looking for guidelines/policies on continuous infusion vesicants for assessments.
Parran L
Oncol Nurs Forum; 2000 Sep; 27(8):1201-2. PubMed ID: 11013900
[No Abstract] [Full Text] [Related]
12. Chemotherapy extravasation: a consequence of fibrin sheath formation around venous access devices.
Mayo DJ; Pearson DC
Oncol Nurs Forum; 1995 May; 22(4):675-80. PubMed ID: 7675669
[TBL] [Abstract][Full Text] [Related]
13. Vesicant extravasation part I: Mechanisms, pathogenesis, and nursing care to reduce risk.
Sauerland C; Engelking C; Wickham R; Corbi D
Oncol Nurs Forum; 2006 Nov; 33(6):1134-41. PubMed ID: 17149396
[TBL] [Abstract][Full Text] [Related]
14. European Oncology Nursing Society extravasation guidelines.
Wengström Y; Margulies A;
Eur J Oncol Nurs; 2008 Sep; 12(4):357-61. PubMed ID: 18765210
[TBL] [Abstract][Full Text] [Related]
15. [The extravasation of vesicant drugs: a report of experience].
da Silva AC
Rev Paul Enferm; 1992; 11(1):27-9. PubMed ID: 1284856
[No Abstract] [Full Text] [Related]
16. Mediastinal extravasation of doxorubicin.
Quintanar Verdúguez T; Blanco Jarava A; Martínez-Barbeito MB; Pangua Méndez C; López Gómez L; Andrade Santiago J; Chacón López-Muñiz I
Clin Transl Oncol; 2008 Feb; 10(2):128-30. PubMed ID: 18258513
[TBL] [Abstract][Full Text] [Related]
17. Propofol extravasation in a breast cancer patient.
Huijbers EJ; Baars JW; Schutte PF; Schellens JH; Beijnen JH
J Oncol Pharm Pract; 2008 Dec; 14(4):195-8. PubMed ID: 18753182
[TBL] [Abstract][Full Text] [Related]
18. [If it spills a bit... extravasations as complications of infusion therapy].
Wagner EM
Kinderkrankenschwester; 2003 Dec; 22(12):507-11. PubMed ID: 16134686
[No Abstract] [Full Text] [Related]
19. [Implanted venous access system in oncology. Review of 296 cases].
Guenier C; Nogaret JM; Ferreira J; Lorent I; Pector JC
Ann Chir; 1990; 44(5):388-91. PubMed ID: 2372203
[TBL] [Abstract][Full Text] [Related]
20. Identifying complications of central venous catheters: infection, thrombosis, occlusion.
Prescrire Int; 2009 Aug; 18(102):173-4. PubMed ID: 19746562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
